Melanie Börries: Cancer Research & The Symphony of Science
- Melanie Börries, a researcher at the University Hospital Freiburg, has been awarded the german Cancer Prize 2025 for her innovative work in personalized cancer therapy, which...
- "It is my big vision to bring the knowledge from the laboratory together with the data from everyday clinical practice in order to find the best possible...
- This article is available exclusively with a BZ digital subscription.
Melanie Börries Awarded German Cancer Prize for Personalized Therapy Research
Table of Contents
Cancer Research
Melanie Börries, a researcher at the University Hospital Freiburg, has been awarded the german Cancer Prize 2025 for her innovative work in personalized cancer therapy, which includes breeding mini-tumors, scanning data, and extensive networking.
Vision for Personalized Cancer Treatment
”It is my big vision to bring the knowledge from the laboratory together with the data from everyday clinical practice in order to find the best possible therapy for every patient,” says Melanie Börries. This vision, according to Börries, has been taking shape over several years.
Details on Subscription
This article is available exclusively with a BZ digital subscription.
BZ digital basis
Read more directly with BZ digital basis:
3 sweet
3 € / month then € 15.90 / month
- All articles free on badische-zeitung.de
- News-App BZ-Smart
- Leisure app BZ favorite places
Subscribe now
can be canceled after 3 months at any time
Subscribe in the printed Badische Zeitung? Unlock free digital access here.
Already a digital subscriber? Log in.
Melanie Börries and the Future of Cancer Treatment: Your Questions Answered
Q: Who is Melanie Börries, and what is she known for?
A: Melanie Börries is a researcher at the University Hospital Freiburg. She recently received the German Cancer Prize 2025 for her groundbreaking work in personalized cancer therapy. This innovative approach involves several key components, including:
Breeding mini-tumors
Scanning data
Extensive networking
Q: What is personalized cancer therapy, and why is it important?
A: Personalized cancer therapy aims to tailor treatment plans to the specific characteristics of each patient’s cancer. This offers the potential for more effective treatments with fewer side effects.
Q: what is Melanie Börries’ vision for the future of cancer treatment?
A: Börries envisions bringing together laboratory knowledge with data from everyday clinical practice. Her goal is to identify the best possible therapy for every patient.
Q: How can I read the full article about Melanie Börries’ work?
A: The full article is available exclusively to subscribers of the BZ digital service.
Q: What are the subscription options for accessing BZ digital content?
A: The “BZ digital basis” subscription offers access to articles and includes the following benefits:
All articles free on badische-zeitung.de
News-App BZ-Smart
Leisure app BZ favorite places
Q: What is the cost of the “BZ digital basis” subscription?
A: The subscription costs 3 € per month for the first three months,then increases to 15.90 € per month.
Q: Can I cancel the “BZ digital basis” subscription?
A: Yes, the subscription can be canceled after 3 months at any time.
Q: What if I subscribe to the printed Badische Zeitung?
A: If you subscribe to the printed version of the Badische Zeitung, you can unlock free digital access.
Q: I am already a digital subscriber. How do I access the content?
A: if you’re already a digital subscriber, you can log in to access the article.